Bovine Dialyzable Leukocyte Extract IMMUNEPOTENT CRP: Evaluation of Biological Activity of the Modified Product

Dialyzable leukocyte extracts are clinically used under different commercial names (IMMUNEPOTENT CRP<sup>®</sup>, IMMODIN<sup>®</sup>, Transferon<sup>®</sup>) to modulate the immune response altered by pathological conditions such as cancer, inflammation, and vira...

Full description

Bibliographic Details
Main Authors: Moisés Armides Franco-Molina, Silvia Elena Santana-Krímskaya, Diana Ginette Zarate-Triviño, Pablo Zapata-Benavides, Sara Paola Hernández-Martínez, Fernanda Cervantes-Wong, Cristina Rodríguez-Padilla
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Applied Sciences
Subjects:
Online Access:https://www.mdpi.com/2076-3417/11/8/3505
_version_ 1797537737275867136
author Moisés Armides Franco-Molina
Silvia Elena Santana-Krímskaya
Diana Ginette Zarate-Triviño
Pablo Zapata-Benavides
Sara Paola Hernández-Martínez
Fernanda Cervantes-Wong
Cristina Rodríguez-Padilla
author_facet Moisés Armides Franco-Molina
Silvia Elena Santana-Krímskaya
Diana Ginette Zarate-Triviño
Pablo Zapata-Benavides
Sara Paola Hernández-Martínez
Fernanda Cervantes-Wong
Cristina Rodríguez-Padilla
author_sort Moisés Armides Franco-Molina
collection DOAJ
description Dialyzable leukocyte extracts are clinically used under different commercial names (IMMUNEPOTENT CRP<sup>®</sup>, IMMODIN<sup>®</sup>, Transferon<sup>®</sup>) to modulate the immune response altered by pathological conditions such as cancer, inflammation, and viral infections. The purpose of this study is to improve the production process of bovine dialyzable leukocyte extract without decreasing its biological activities (antioxidant, anti-inflammatory, and antitumoral). Our product modification consists of adding a dry heating step in the production process. In this study, we evaluated and compared the chemical composition (bromatological analysis), physical structure (infrared spectroscopy, X-ray diffraction, SEM, and zeta potential) and biological function of the dialyzable leukocyte extracts obtained from fresh and dry bovine spleens. Our results showed that the use of a drying step in the production process of the bovine dialyzable leukocyte extract (bDLE) did not affect its antioxidant and anti-inflammatory effects and it improved its antitumor properties. We suggest that this process modification could be applied to other biological products, such as dialyzable leukocyte extracts derived from other sources, in order to improve its functionality and formulation.
first_indexed 2024-03-10T12:20:28Z
format Article
id doaj.art-9e14012b752d4b4cb6c3d0240f3c9650
institution Directory Open Access Journal
issn 2076-3417
language English
last_indexed 2024-03-10T12:20:28Z
publishDate 2021-04-01
publisher MDPI AG
record_format Article
series Applied Sciences
spelling doaj.art-9e14012b752d4b4cb6c3d0240f3c96502023-11-21T15:31:22ZengMDPI AGApplied Sciences2076-34172021-04-01118350510.3390/app11083505Bovine Dialyzable Leukocyte Extract IMMUNEPOTENT CRP: Evaluation of Biological Activity of the Modified ProductMoisés Armides Franco-Molina0Silvia Elena Santana-Krímskaya1Diana Ginette Zarate-Triviño2Pablo Zapata-Benavides3Sara Paola Hernández-Martínez4Fernanda Cervantes-Wong5Cristina Rodríguez-Padilla6Laboratorio de Inmunología y Virología, Facultad de Ciencias Biológicas, Universidad Autónoma de Nuevo León (UANL), P.O. Box 46 “F”, San Nicolás de los Garza 66455, MexicoLaboratorio de Inmunología y Virología, Facultad de Ciencias Biológicas, Universidad Autónoma de Nuevo León (UANL), P.O. Box 46 “F”, San Nicolás de los Garza 66455, MexicoLaboratorio de Inmunología y Virología, Facultad de Ciencias Biológicas, Universidad Autónoma de Nuevo León (UANL), P.O. Box 46 “F”, San Nicolás de los Garza 66455, MexicoLaboratorio de Inmunología y Virología, Facultad de Ciencias Biológicas, Universidad Autónoma de Nuevo León (UANL), P.O. Box 46 “F”, San Nicolás de los Garza 66455, MexicoLaboratorio de Inmunología y Virología, Facultad de Ciencias Biológicas, Universidad Autónoma de Nuevo León (UANL), P.O. Box 46 “F”, San Nicolás de los Garza 66455, MexicoLaboratorio de Inmunología y Virología, Facultad de Ciencias Biológicas, Universidad Autónoma de Nuevo León (UANL), P.O. Box 46 “F”, San Nicolás de los Garza 66455, MexicoLaboratorio de Inmunología y Virología, Facultad de Ciencias Biológicas, Universidad Autónoma de Nuevo León (UANL), P.O. Box 46 “F”, San Nicolás de los Garza 66455, MexicoDialyzable leukocyte extracts are clinically used under different commercial names (IMMUNEPOTENT CRP<sup>®</sup>, IMMODIN<sup>®</sup>, Transferon<sup>®</sup>) to modulate the immune response altered by pathological conditions such as cancer, inflammation, and viral infections. The purpose of this study is to improve the production process of bovine dialyzable leukocyte extract without decreasing its biological activities (antioxidant, anti-inflammatory, and antitumoral). Our product modification consists of adding a dry heating step in the production process. In this study, we evaluated and compared the chemical composition (bromatological analysis), physical structure (infrared spectroscopy, X-ray diffraction, SEM, and zeta potential) and biological function of the dialyzable leukocyte extracts obtained from fresh and dry bovine spleens. Our results showed that the use of a drying step in the production process of the bovine dialyzable leukocyte extract (bDLE) did not affect its antioxidant and anti-inflammatory effects and it improved its antitumor properties. We suggest that this process modification could be applied to other biological products, such as dialyzable leukocyte extracts derived from other sources, in order to improve its functionality and formulation.https://www.mdpi.com/2076-3417/11/8/3505dialyzable leukocyte extractcharacterizationimmunotherapyantioxidantanti-inflammatoryantitumor
spellingShingle Moisés Armides Franco-Molina
Silvia Elena Santana-Krímskaya
Diana Ginette Zarate-Triviño
Pablo Zapata-Benavides
Sara Paola Hernández-Martínez
Fernanda Cervantes-Wong
Cristina Rodríguez-Padilla
Bovine Dialyzable Leukocyte Extract IMMUNEPOTENT CRP: Evaluation of Biological Activity of the Modified Product
Applied Sciences
dialyzable leukocyte extract
characterization
immunotherapy
antioxidant
anti-inflammatory
antitumor
title Bovine Dialyzable Leukocyte Extract IMMUNEPOTENT CRP: Evaluation of Biological Activity of the Modified Product
title_full Bovine Dialyzable Leukocyte Extract IMMUNEPOTENT CRP: Evaluation of Biological Activity of the Modified Product
title_fullStr Bovine Dialyzable Leukocyte Extract IMMUNEPOTENT CRP: Evaluation of Biological Activity of the Modified Product
title_full_unstemmed Bovine Dialyzable Leukocyte Extract IMMUNEPOTENT CRP: Evaluation of Biological Activity of the Modified Product
title_short Bovine Dialyzable Leukocyte Extract IMMUNEPOTENT CRP: Evaluation of Biological Activity of the Modified Product
title_sort bovine dialyzable leukocyte extract immunepotent crp evaluation of biological activity of the modified product
topic dialyzable leukocyte extract
characterization
immunotherapy
antioxidant
anti-inflammatory
antitumor
url https://www.mdpi.com/2076-3417/11/8/3505
work_keys_str_mv AT moisesarmidesfrancomolina bovinedialyzableleukocyteextractimmunepotentcrpevaluationofbiologicalactivityofthemodifiedproduct
AT silviaelenasantanakrimskaya bovinedialyzableleukocyteextractimmunepotentcrpevaluationofbiologicalactivityofthemodifiedproduct
AT dianaginettezaratetrivino bovinedialyzableleukocyteextractimmunepotentcrpevaluationofbiologicalactivityofthemodifiedproduct
AT pablozapatabenavides bovinedialyzableleukocyteextractimmunepotentcrpevaluationofbiologicalactivityofthemodifiedproduct
AT sarapaolahernandezmartinez bovinedialyzableleukocyteextractimmunepotentcrpevaluationofbiologicalactivityofthemodifiedproduct
AT fernandacervanteswong bovinedialyzableleukocyteextractimmunepotentcrpevaluationofbiologicalactivityofthemodifiedproduct
AT cristinarodriguezpadilla bovinedialyzableleukocyteextractimmunepotentcrpevaluationofbiologicalactivityofthemodifiedproduct